GSK BEconneCTD-ILD Patient
com.medable.gsk221672.patient
50+
installs · ≈61
—
0 ratings
2024-07-23
first release
2024-08-02
last update
Description
A study for patients with interstitial lung disease (ILD) associated with CTD
This app has been exclusively created for participants in the medical study for GSK BE-conneCTD ILD 221672. It contains Televisit functionality and allows participants to complete questionnaires.
A Phase 3, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of belimumab administered subcutaneously in adults with interstitial lung disease (ILD) associated with connected tissue disease (CTD).
Details
| Version | 5.4.700.5-prod |
|---|---|
| Minimum Android version | 8.0 |
| Reviews | 0 |
| Available in | Argentina, American Samoa, Australia, Belgium, Bulgaria, Brazil, Canada, Germany, Spain, United Kingdom, Greece, Guam and 13 more |
| Developer contacts | on the Business plan |
| Collected | 2026-11-15 |
This data in the API
The full record in JSON costs 1 token.
curl -H "X-API-Key: YOUR_KEY" \ "https://apkapi.com/api/v1/app?id=com.medable.gsk221672.patient"
